Docs express concern over recommendation on nonroller pumps

01/7/2013 | MedPage Today (free registration)

If the FDA follows a panel recommendation, the manufacturers of certain nonroller blood pumps for hemodynamic support will have to to go through the full premarket approval process, something that worries clinicians. "If the FDA reclassified these devices and required a premarket approval, it might put a taint on them and doctors would be less comfortable using them and patients would question them," said SCAI Past President Dr. George Vetrovec, who spoke on behalf of the organization.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN